These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10535660)

  • 1. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
    D'Amours M; Lebel M; Grose JH; Larivière R
    Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R; Lebel M; Kingma I; Grose JH; Boucher D
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
    Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
    Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT.
    Fortepiani LA; Ruiz MC; Passardi F; Bentley MD; Garcia-Estan J; Ritman EL; Romero JC
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F852-60. PubMed ID: 12837684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
    Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
    Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of angiotensin II receptors after chronic inhibition of nitric oxide synthase in the spontaneously hypertensive rat.
    Yang Y; Macdonald GJ; Duggan KA
    Clin Exp Pharmacol Physiol; 1996 May; 23(5):441-3. PubMed ID: 8713687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats.
    Sventek P; Turgeon A; Schiffrin EL
    Circulation; 1997 Jan; 95(1):240-4. PubMed ID: 8994442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition.
    Ortíz MC; Fortepiani LA; Ruiz-Marcos FM; Atucha NM; García-Estañ J
    Am J Physiol; 1998 Mar; 274(3):R760-6. PubMed ID: 9580145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
    Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
    Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
    Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
    Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous and endogenous angiotensin II on intrarenal distribution of glomerular filtration rate in rats.
    Treeck B; Roald AB; Tenstad O; Aukland K
    J Physiol; 2002 Jun; 541(Pt 3):1049-57. PubMed ID: 12068062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.